Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting

✍ Scribed by L. H. J. Eberhart; M. Mauch; A. M. Morin; H. Wulf; G. Geldner

• Publisher: John Wiley and Sons
• Year: 2002
• Tongue: English
• Weight: 195 KB
• Volume: 57
• Category: Article
• ISSN: 0003-2409
• DOI: 10.1046/j.1365-2044.2002.02822.x

✦ Synopsis

Summary

Postoperative nausea and vomiting (PONV) are frequent and unpleasant symptoms. This prospective study aimed to assess the efficacy of a multimodal approach to prevent PONV, and patient satisfaction using the willingness‐to‐pay method. Two validated risk scores were applied to forecast the individual risk for PONV in 900 consecutive patients of whom 108 were identified as high‐risk patients (predicted risk: 79–87%). High‐risk patients received multimodal anti‐emetic prophylaxis: total intravenous anaesthesia with propofol, high fractional inspired oxygen (80%), omission of nitrous oxide, dexamethasone 8 mg, haloperidol 10 µg.kg^−1^, and tropisetron 2 mg. Of the remaining patients with low or moderate risk for PONV, a random sample of 71 females received balanced propofol‐desflurane anaesthesia without prophylactic anti‐emetics. All patients were interviewed 2 and 24 h after surgery for occurrence of nausea and vomiting. Patient satisfaction was measured using the willingness‐to‐pay method. The incidence of PONV (95%‐confidence interval) in the control‐group was 41% (29–51%), slightly lower than predicted by the risk scores (53–57%). The multimodal anti‐emetic approach reduced the predicted risk (79–87%) in the high risk‐group to 7% (3–14%). This was associated with a high willingness‐to‐pay median (25th/75th percentile) of £84 (£33–184) in the multimodal anti‐emetic grouped compared to £14 (£4–30) in the control group. A multimodal anti‐emetic approach can considerably reduce the incidence of PONV in high‐risk patients and is associated with a high patient satisfaction as measured by the willingness‐to‐pay method.